Interventional Radiology Market Size, Share, Competitive Landscape and Trend Analysis Report, by Technology, by Application : Global Report opportunity Analysis and Industry Forecast, 2023-2033

Interventional radiology involves the use of minimally-invasive imaging guided techniques to diagnose and treat diseases. Considering its wide range of applications in detection and treatment of several diseases and technological advancements, the field of interventional radiology has expanded widely.

The rising incidence of chronic diseases such as blood vessel diseases and the development of new techniques in the market such as Optical Coherence Tomography (OCT) & Fractional Flow Reserve (FFR) are the major driving factors of this market. However, high costs of equipment and the need for efficient handling techniques may hinder the market growth. Recent advancements and the development of modified techniques provide high opportunities for market expansion.

The global interventional radiology market is segmented on the basis of technology into catheters, stents, angioplasty balloons, IVC filters, biopsy needles, and HFA devices. On the basis of application, the market is divided into oncology, cardiology, urology & nephrology, and gastroenterology. Geographically, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The leading players in the global interventional radiology market are Fujifilm Holdings Corp, Agfa-Gevaert NV & Co. KG, Hologic, Inc., Koninklijke Philips N.V., Carestream Health, Inc., Medtronic PLC., Biosensor International Group, Ltd., Stryker Corporation, and Cook Group Incorporated.

Key Benefits

• The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors.
• This report provides an extensive analysis of the current and emerging market trends and dynamics in the global interventional radiology market that helps identify upcoming market opportunities.
• Competitive intelligence (of leading manufacturers and distributors) helps understand the competitive scenario across geographies.
• Recent industry trends & developments and future opportunities have also been covered.
• Extensive knowledge of key market players and their strategies has been provided.
• Geographically the world interventional radiology market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
• A comprehensive analysis of various factors that drive and restrain the growth of this market has been provided.

  Interventional Radiology Market Report Highlights

Aspects	Details
By Technology	Catheters Diagnostics Catheters Therapeutics Catheters Stents Diagnostics Stents Therapeutics Stents Inferior Vena Cava (IVC) Filters Hemodynamic Flow Alteration Devices(HFA devices) Angioplasty Balloons Thrombectomy Systems Biopsy Needles Embolization by Product Embolic Coils Detachable Coils Pushable Coils Embolic Agents Liquid Embolic Agents Microspheres Detachable Balloon Embolic Plug System Support Devices by Procedure Transcatheter Arterial Embolization (TAE) Transcatheter Arterial Radioembolization (TARE) Transarterial Chemoembolization (TACE) cTACE DEB-TACE Accessories Others
By Application	Oncology Cardiology Urology and Nephrology Gastroenterology Other Applications
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	GE Healthcare (General Electric Company) (U.K.), Fujifilm Holdings Corp, Agfa-Gevaert NV And Co. KG, Medtronic PLC., Koninklijke Philips N.V., Stryker Corporation, AstraZeneca, Hologic, Inc., Cook Group Incorporated, Biosensor International Group, Ltd., Carestream Health, Inc.

^*Terms and Conditions Apply